| pubmed-article:20216421 | pubmed:abstractText | The aim is to review briefly the problems related to treatment of drug-susceptible and drug-resistant tuberculosis (TB), describe recent advances in the development of new drugs and new regimens, and discuss implications for control programmes. | lld:pubmed |
